Regulation of the Caenorhabditis Elegans Oxidative Stress Defense Protein SKN-1 by Glycogen Synthase Kinase-3

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Oct 28

PMID 16251270

Citations 127

Authors

Jae Hyung An

Kelly Vranas

Michael Lucke

Hideki Inoue

Naoki Hisamoto

Kunihiro Matsumoto

T Keith Blackwell

Affiliations

Soon will be listed here.

Abstract

Oxidative stress plays a central role in many human diseases and in aging. In Caenorhabditis elegans the SKN-1 protein induces phase II detoxification gene transcription, a conserved oxidative stress response, and is required for oxidative stress resistance and longevity. Oxidative stress induces SKN-1 to accumulate in intestinal nuclei, depending on p38 mitogen-activated protein kinase signaling. Here we show that, in the absence of stress, phosphorylation by glycogen synthase kinase-3 (GSK-3) prevents SKN-1 from accumulating in nuclei and functioning constitutively in the intestine. GSK-3 sites are conserved in mammalian SKN-1 orthologs, indicating that this level of regulation may be conserved. If inhibition by GSK-3 is blocked, background levels of p38 signaling are still required for SKN-1 function. WT and constitutively nuclear SKN-1 comparably rescue the skn-1 oxidative stress sensitivity, suggesting that an inducible phase II response may provide optimal stress protection. We conclude that (i) GSK-3 inhibits SKN-1 activity in the intestine, (ii) the phase II response integrates multiple regulatory signals, and (iii), by inhibiting this response, GSK-3 may influence redox conditions.

Citing Articles

Protein sequence editing defines distinct and overlapping functions of SKN-1A/Nrf1 and SKN-1C/Nrf2.

Jochim B, Topalidou I, Lehrbach N bioRxiv. 2025; .

PMID: 39975340 PMC: 11838306. DOI: 10.1101/2025.01.29.635299.

Norharmane prevents muscle aging via activation of SKN-1/NRF2 stress response pathways.

Nirmala F, Lee H, Cho Y, Um M, Seo H, Jung C Redox Biol. 2025; 80:103512.

PMID: 39874928 PMC: 11810848. DOI: 10.1016/j.redox.2025.103512.

An insulin-like signalling pathway model for Fasciola gigantica.

Wu D, Yang Y, Yang Y, Li L, Fu S, Wang L BMC Vet Res. 2024; 20(1):252.

PMID: 38851737 PMC: 11162077. DOI: 10.1186/s12917-024-04107-7.

Low-dose naltrexone extends healthspan and lifespan in via SKN-1 activation.

Li W, McIntyre R, Schomakers B, Kamble R, Luesink A, van Weeghel M iScience. 2024; 27(6):109949.

PMID: 38799567 PMC: 11126937. DOI: 10.1016/j.isci.2024.109949.

Disrupting the SKN-1 homeostat: mechanistic insights and phenotypic outcomes.

Turner C, Ramos C, Curran S Front Aging. 2024; 5:1369740.

PMID: 38501033 PMC: 10944932. DOI: 10.3389/fragi.2024.1369740.

References

Walker A, See R, Batchelder C, Kophengnavong T, Gronniger J, Shi Y . A conserved transcription motif suggesting functional parallels between Caenorhabditis elegans SKN-1 and Cap'n'Collar-related basic leucine zipper proteins. J Biol Chem. 2000; 275(29):22166-71. DOI: 10.1074/jbc.M001746200. View

Yaffe M, Leparc G, Lai J, Obata T, Volinia S, Cantley L . A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol. 2001; 19(4):348-53. DOI: 10.1038/86737. View

Sagasti A, HISAMOTO N, Hyodo J, Matsumoto K, Bargmann C . The CaMKII UNC-43 activates the MAPKKK NSY-1 to execute a lateral signaling decision required for asymmetric olfactory neuron fates. Cell. 2001; 105(2):221-32. DOI: 10.1016/s0092-8674(01)00313-0. View

Toone W, Morgan B, Jones N . Redox control of AP-1-like factors in yeast and beyond. Oncogene. 2001; 20(19):2336-46. DOI: 10.1038/sj.onc.1204384. View

Maduro M, Meneghini M, Bowerman B, Broitman-Maduro G, Rothman J . Restriction of mesendoderm to a single blastomere by the combined action of SKN-1 and a GSK-3beta homolog is mediated by MED-1 and -2 in C. elegans. Mol Cell. 2001; 7(3):475-85. DOI: 10.1016/s1097-2765(01)00195-2. View

Cohen P, Frame S . The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001; 2(10):769-76. DOI: 10.1038/35096075. View

Hayes J, McMahon M . Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 2001; 174(2):103-13. DOI: 10.1016/s0304-3835(01)00695-4. View

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

Droge W . Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82(1):47-95. DOI: 10.1152/physrev.00018.2001. View

10.

Liu C, Li Y, Semenov M, Han C, Baeg G, Tan Y . Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002; 108(6):837-47. DOI: 10.1016/s0092-8674(02)00685-2. View

11.

Harwood A . Signal transduction in development: holding the key. Dev Cell. 2002; 2(4):384-5. DOI: 10.1016/s1534-5807(02)00156-9. View

12.

Kim D, Feinbaum R, Alloing G, Emerson F, Garsin D, Inoue H . A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science. 2002; 297(5581):623-6. DOI: 10.1126/science.1073759. View

13.

Sheetz M, King G . Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 2002; 288(20):2579-88. DOI: 10.1001/jama.288.20.2579. View

14.

Nguyen T, Sherratt P, Pickett C . Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol. 2002; 43:233-60. DOI: 10.1146/annurev.pharmtox.43.100901.140229. View

15.

An J, Blackwell T . SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev. 2003; 17(15):1882-93. PMC: 196237. DOI: 10.1101/gad.1107803. View

16.

Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

17.

Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S . Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003; 35(3):238-45. DOI: 10.1038/ng1248. View

18.

Jope R, Johnson G . The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004; 29(2):95-102. DOI: 10.1016/j.tibs.2003.12.004. View

19.

Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

20.

Andersen J . Oxidative stress in neurodegeneration: cause or consequence?. Nat Med. 2004; 10 Suppl:S18-25. DOI: 10.1038/nrn1434. View